Goh, E. T. et al.
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy.
Cochrane Database Syst Rev, 2018·DOI: 10.1002/14651858.CD012410.pub2
- Mortalität
- −43% vs. Placebo
- HE-Symptome
- Sign. p < 0.001
- Ammoniak
- ↓
- Studientyp
- Meta-Analyse